SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001393825-18-000023
Filing Date
2018-02-02
Accepted
2018-02-02 14:12:32
Documents
1

Document Format Files

Seq Description Document Type Size
1 CYCLACEL PHARMACEUTICALS, INC. SC13G CYCC-13G.htm SC 13G 58655
  Complete submission text file 0001393825-18-000023.txt   60373
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Subject) CIK: 0001130166 (see all company filings)

IRS No.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-80136 | Film No.: 18569982
SIC: 2834 Pharmaceutical Preparations

Mailing Address 777 THIRD AVE., 30TH FLOOR NEW YORK NY 10017
Business Address 777 THIRD AVE., 30TH FLOOR NEW YORK NY 10017 212-571-1244
Hudson Bay Capital Management LP (Filed by) CIK: 0001393825 (see all company filings)

IRS No.: 371511173 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G